BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

CUSIP: 10806X102

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
191,564,221
Total 13F shares
103,303,295
Share change
+5,404,075
Total reported value
$2,217,864,724
Price per share
$21.47
Number of holders
75
Value change
+$112,320,073
Number of buys
49
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 10806X102?
CUSIP 10806X102 identifies BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) as of Q3 2019

As of 30 Sep 2019, BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 103,303,295 shares. The largest 10 holders included Kohlberg Kravis Roberts & Co. L.P., VIKING GLOBAL INVESTORS LP, AMERICAN INTERNATIONAL GROUP INC, PERCEPTIVE ADVISORS LLC, HILLHOUSE CAPITAL ADVISORS, LTD., Aisling Capital Management LP, FMR LLC, Cormorant Asset Management, LP, SC US (TTGP), LTD., and VANGUARD GROUP INC. This page lists 75 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.